Clinical Trials
5 trialsNCT00053157 2022-10-05
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
Roswell Park Cancer Institute
Phase NA Completed
NCT02786719 2020-03-12
SPRING
Baylor College of Medicine
Phase NA Completed
NCT00665002 2015-02-27
Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT00006243 2013-01-25
Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma
National Cancer Institute (NCI)
Phase NA Completed
NCT00899821 2012-11-09
Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer
NYU Langone Health
Phase NA Completed